- Filed
- Mar 10, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Mar 10, 2026 | 7.25M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 2.8M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 2.34M sh |
| Shares Diluted restated | Q2 2026 · Jan 31, 2025 | 269.96K sh |
| Shares Diluted restated | Q2 2026 · Jan 31, 2025 | 222.5K sh |
| Operating Cash Flow | Q2 2026 · Jan 31, 2026 | −$15.67M |
| Operating Cash Flow | Q2 2026 · Jan 31, 2025 | −$12.88M |
| Cash And Equivalents | Q2 2026 · Jan 31, 2026 | $29.9M |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $10.49M |
| Current Liabilities | Q2 2026 · Jan 31, 2026 | $3.19M |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $3.98M |
| Current Assets | Q2 2026 · Jan 31, 2026 | $32.18M |
| Current Assets | Q2 2026 · Jul 31, 2025 | $19.93M |
| Total Assets | Q2 2026 · Jan 31, 2026 | $33.59M |
| Total Assets | Q2 2026 · Jul 31, 2025 | $21.65M |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | −$2.58 |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | −$6.58 |
| Eps Diluted restated | Q2 2026 · Jan 31, 2025 | −$23.31 |
| Eps Diluted restated | Q2 2026 · Jan 31, 2025 | −$54.35 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | −$2.58 |
| Eps Basic restated | Q2 2026 · Jan 31, 2025 | −$23.31 |
| Eps Basic restated | Q2 2026 · Jan 31, 2025 | −$54.35 |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $1.48M |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $3.12M |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $1.48M |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $2.97M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $6.05M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $12.74M |
| Rd Expense | Q2 2026 · Jan 31, 2025 | $5.68M |
| Rd Expense | Q2 2026 · Jan 31, 2025 | $9.35M |
| Net Income | Q2 2026 · Jan 31, 2026 | −$7.22M |
| Net Income | Q2 2026 · Jan 31, 2026 | −$15.42M |
| Net Income | Q2 2026 · Jan 31, 2025 | −$6.29M |
| Net Income | Q2 2026 · Jan 31, 2025 | −$12.09M |
| Operating Income | Q2 2026 · Jan 31, 2026 | −$7.53M |
| Operating Income | Q2 2026 · Jan 31, 2026 | −$15.85M |
| Operating Income | Q2 2026 · Jan 31, 2025 | −$7.17M |
| Operating Income | Q2 2026 · Jan 31, 2025 | −$12.32M |
| Short Term Investments | Q2 2026 · Jul 31, 2025 | $7.37M |